News & Articles

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA

Register for this webinar to learn more about STARLIMS and how it can be used to suport the entire life-cycle of your samples

Seeking a shortcut to treatment for the novel coronavirus pandemic, Sanofi and Regeneron will roll out phase 2/3 trials of the arthritis drug

The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes

IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19

Join this webinar with Dr. Maurizio Morri, Chan Zuckerberg Biohub, for insight on how to choose the right technique for your study

The FDA has issued its fourth Emergency Use Authorization for coronavirus tests, this time to Thermo Fisher Scientific for its TaqPath COVID-19 Combo Kit

The first commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs

Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020

Ellutia is presenting its nitrosamine testing solution for pharmaceuticals using its 800 Series Thermal Energy Analyser with Chemical Stripping System

The new kit promises enhanced performance and flexibility to power cancer and genetics research

New Gallant high-voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity

Positive in vivo efficacy and pharmacokinetic data shows AVA04-VbP drug conjugate out-performed Bavencio immunotherapy

Free yourself from the time-consuming burden of picking sample tubes and embrace a fresh, new perspective

The change of name is a contractual requirement of its divestment from TTP Group in 2018 with the backing of technology-focused investment firm Battery Ventures

The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia

PWC-Colorcon-TruTag technology coalition prove out the mass digitalization of pharma pills